June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Vitritis in pediatric retinal degenerations
Author Affiliations & Notes
  • Maria Stunkel
    Ophthalmology, University of Iowa, Iowa City, IA
  • Sajag Bhattarai
    Ophthalmology, University of Iowa, Iowa City, IA
  • Edwin Stone
    Ophthalmology, University of Iowa, Iowa City, IA
  • Kai Wang
    Biostatistics, University of Iowa, Iowa City, IA
  • Robert Mullins
    Ophthalmology, University of Iowa, Iowa City, IA
  • Arlene Drack
    Ophthalmology, University of Iowa, Iowa City, IA
  • Footnotes
    Commercial Relationships Maria Stunkel, None; Sajag Bhattarai, None; Edwin Stone, None; Kai Wang, None; Robert Mullins, Alcon Research Ltd (F); Arlene Drack, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1168. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Stunkel, Sajag Bhattarai, Edwin Stone, Kai Wang, Robert Mullins, Arlene Drack; Vitritis in pediatric retinal degenerations. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1168. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Cells can be observed in the anterior vitreous (AV) of many patients with genetic retinal degenerations. This may represent inflammation with diagnostic, prognostic and therapeutic significance.

Methods: Retrospective chart review of patients presenting with suspected retinal degeneration to a single examiner from 2008-2012. Age, visual acuity (VA), slit lamp examination (SLE) of AV, clinical and molecular genetic diagnoses were documented. Data was analyzed using Student’s t-test and Fisher exact test.

Results: 106 charts were identified; 2 were excluded as unaffected siblings. 66/104 (63.5%) had SLE of AV data recorded. SLE could not be accomplished in 38/104 (36.5%) due to youth (average age 9.3 years with SLE vs. 3.3 without, p=2.1x10-12). 42/66 (63.6%) had no vitritis. 20/66 (30.3%) had 1+ or greater cells. 4/66 (6.1%) had rare cells. Average age between cells and no-cells (9.6 vs. 9.5 years) did not differ significantly. VA averaged 20/142 with cells; 20/419 no-cells (p=0.068). Diagnoses with cells: BBS(5), LCA(5), RP(5), Usher(2), CLN3(1), JXLR(1), possible Stargardt(1). Diagnoses without cells: CSNB(12), LCA(8), Stargardt(5), blue cone monochromacy(4), RP(3), achromatopsia(2), JXLR (2), nystagmus(2), CLN1(1), Joubert(1), Cobalamin G deficiency(1), autism/obesity(1). 5/20 patients with cells had BBS vs. 0/42 patients without (p=0.002). 12/42 patients without cells had CSNB compared to 0/20 patients with (p=0.006). Genetic subtypes of LCA did not overlap: RDH12(2), CRX(1) cells; CEP290(3), GUCY2D(2), AIPL1(1) no-cells.

Conclusions: A non-random subset of pediatric retinal degenerations exhibit vitritis. 5/5 BBS patients (progressive) demonstrated cells whereas 0/12 patients with CSNB (stable) did. Studying pediatric retinal degenerations with and without vitritis may elucidate whether inflammation accelerates vision loss in certain subtypes. Potentially, inflammation could be treated. SLE of AV may aid in clinical diagnosis.

Keywords: 696 retinal degenerations: hereditary • 763 vitreous • 464 clinical (human) or epidemiologic studies: risk factor assessment  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.